¼¼°èÀÇ ¸» Áø´Ü ¼­ºñ½º ½ÃÀå
Equine Diagnostic Services
»óǰÄÚµå : 1795911
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 388 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¸» Áø´Ü ¼­ºñ½º ¼¼°è ½ÃÀåÀº 2030³â±îÁö 12¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 8¾ï 40¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸» Áø´Ü ¼­ºñ½º ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 6.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 12¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ ¼­ºñ½º´Â CAGR 8.1%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3¾ï 2,490¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. X¼± ¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 1,810¸¸ ´Þ·¯, Áß±¹Àº CAGR 10.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¸» Áø´Ü ¼­ºñ½º ½ÃÀåÀº 2024³â¿¡ 2¾ï 1,810¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 10.5%¸¦ ±â·ÏÇϸç 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 2¾ï 4,450¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.1%¿Í 6.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¸» Áø´Ü ¼­ºñ½º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Áø´Ü ¼­ºñ½º´Â ¸»ÀÇ °Ç°­ °ü¸® ¹× ¼º´É ¸ð´ÏÅ͸µÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

¸» Áø´Ü ¼­ºñ½º´Â ¸»ÀÇ Áúº´, ºÎ»ó, ¼º´É ¹®Á¦¸¦ °¨Áö, Æò°¡, °ü¸®ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º¿¡´Â ¼öÀÇ»ç¿Í ¸» °ü¸®»ç°¡ ¸»ÀÇ °Ç°­, »ý»ê¼º, ¿îµ¿ ´É·ÂÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ÀÓ»ó °Ë»ç, ¿µ»ó ±â¼ú, »ý¸®Àû Æò°¡ µîÀÌ Æ÷ÇԵ˴ϴÙ. Áø´Ü µµ±¸´Â ƯÈ÷ ÁøÇàµÇ±â Àü±îÁö´Â ´«¿¡ º¸ÀÌ´Â Áõ»óÀÌ ³ªÅ¸³ªÁö ¾Ê´Â Áúȯ¿¡ ´ëÇÑ Á¶±â °³ÀÔ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

ÀϹÝÀûÀ¸·Î ½ÃÇàµÇ´Â Áø´Ü¿¡´Â Ç÷¾×°Ë»ç, ºÐº¯°Ë»ç, °üÀý¾× ºÐ¼®, ¹ø½ÄÆò°¡, ÃÊÀ½ÆÄ °Ë»ç, ¿¢½º·¹ÀÌ ÃÔ¿µ, ³»½Ã°æ °Ë»ç µî °íµµÀÇ ¿µ»ó Áø´ÜÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ÆÄÇà, È£Èí±âÁúȯ, ¼ÒÈ­±â Áúȯ, °¨¿°¼º ÁúȯÀÇ ¹ß°ß¿¡ ÇʼöÀûÀÔ´Ï´Ù. °æÀ︶¿Í ¹ø½Ä¸¶ÀÇ °æ¿ì, Áø´ÜÀº ¹ø½Ä ´É·Â Æò°¡, ÈÆ·ÃÀÇ ¿µÇâ ¸ð´ÏÅ͸µ, ¼º´É °ü·Ã ºÎ»óÀ» ¿¹¹æÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¸»ÀÇ º¹Áö¿Í ½ºÆ÷Ã÷ °Ç°­À» Áß½ÃÇÏ´Â °æÇâÀÌ ³ô¾ÆÁö¸é¼­ Á¤±âÀûÀ̰í Á¤È®ÇÑ Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸» Áø´ÜÀÇ Á¤È®µµ¿Í ¹üÀ§¸¦ Çâ»ó½ÃŰ´Â ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡?

¸»ÀÇ Áø´Ü ºÐ¾ß´Â ¿µ»ó Áø´Ü, ºÐÀÚ»ý¹°ÇÐ, ÇöÀå Áø·á °Ë»çÀÇ ¹ßÀüÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ¿¢½º·¹ÀÌ ÃÔ¿µ Àåºñ¿Í ÈÞ´ë¿ë ÃÊÀ½ÆÄ Áø´Ü±â´Â ¸¶¹æÀ̳ª °æÁÖÀå¿¡¼­ º¸´Ù ½Å¼ÓÇÏ°í ¼¼¹ÐÇÑ ¿µ»ó Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ³»½Ã°æ °Ë»ç´Â ƯÈ÷ °æÁÖ¸¶ÀÇ È£Èí±â ¹× ¼ÒÈ­°ü Æò°¡¿¡ ÀÚÁÖ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí °Ç°­ ¸ð´ÏÅÍ¿Í º¸Çà ºÐ¼® µµ±¸°¡ µîÀåÇØ ½Ç½Ã°£ ¿îµ¿ ÃßÀû°ú »ýü¿ªÇÐÀû Æò°¡¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

°Ë»ç±â°ü¿¡¼­´Â È£¸£¸ó ÃøÁ¤, Áúȯ ƯÀÌÀû ¸¶Ä¿, À¯Àü¼º Áúȯ ½ºÅ©¸®´× µî º¸´Ù Á¤¹ÐÇÑ Ç÷¾×°Ë»ç¿Í À¯ÀüÀÚ °Ë»ç°¡ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. PCR ±â¹Ý °Ë»ç´Â °¨¿°ÁõÀÇ Á¶±â ¹ß°ßÀ» Çâ»ó½Ã۰í, ½Ç½Ã°£ »ýÈ­ÇÐ ºÐ¼®±â´Â ÀÀ±Þ»óȲ¿¡¼­ ½Å¼ÓÇÑ ´ëÀÀÀ» Áö¿øÇÕ´Ï´Ù. À̵¿½Ä Áø´Ü Àåºñ¿Í µðÁöÅÐ Ç÷§ÆûÀº ¿ø°ÝÁö ¹× ³óÃÌ Áö¿ªÀ¸·ÎÀÇ Á¢±ÙÀ» È®´ëÇÏ°í ¼öÀǻ簡 Ä¡·á ½ÃÁ¡¿¡ °í±Þ Áø´ÜÀ» ½±°Ô Á¦°øÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

Áø´Ü ¼­ºñ½º µµÀÔ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ´Â ºÎ¹®°ú ÀÌÇØ°ü°èÀÚ´Â?

°æÁÖ¸¶, Àå¾Ö¸¶, ¹ø½Ä¸¶´Â °æÁ¦Àû, ÆòÆÇÀû °¡Ä¡°¡ ³ô±â ¶§¹®¿¡ Áø´Ü ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡Àå ³ôÀº ºÎ¹®ÀÔ´Ï´Ù. ÀÌÇØ°ü°èÀÚÀÎ ¸¶ÁÖ, Á¶·Ã»ç, À°Á¾°¡, ¸»ÀÇ ¼öÀÇ»ç´Â °Ç°­ °ü¸®¸¦ ÃÖÀûÈ­ÇÏ°í ¼Õ½ÇÀ» ¹æÁöÇϱâ À§ÇØ µ¥ÀÌÅÍ ±â¹Ý µµ±¸¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù. ´ëÇü ¸» Áø·á¼Ò, ¼öÀǰú´ëÇÐ ¹× Àü¹® ¿¬±¸¼Ò°¡ Á᫐ ¼­ºñ½º Á¦°ø¾÷ü¸¦ Çü¼ºÇϰí ÀÖÀ¸¸ç, ´ëºÎºÐ Á¤¾×Á¦ ¶Ç´Â Á¤±âÀûÀÎ Áø´Ü ÆÐŰÁö¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¿¤¸®Æ® ¸»»Ó¸¸ ¾Æ´Ï¶ó ·¹Àú¿ë ¸», Ä¡·á¿ë ¸»ÀÇ Áø´Ü¿¡ ´ëÇÑ °ü½Éµµ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, µ¿¹°º¹Áö¿Í ¿¹¹æÀÇÇп¡ ´ëÇÑ °ü½Éµµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. º¸Çè»ç³ª ±ÔÁ¦±â°üµµ º¸Çè °¡ÀÔ ÀÚ°ÝÀ̳ª °æÀï Çã°¡¸¦ À§ÇØ Áø´Ü °Ë»ç¸¦ Àǹ«È­ÇÔÀ¸·Î½á ±× ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Àμö°øÅëÀü¿°º´ÀÇ À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¸»ÀÇ º´¿øÃ¼¸¦ Á¶±â¿¡ ¹ß°ßÇÏ´Â °ÍÀÌ ¸»ÀÇ °³Ã¼±º °ü¸®¿Í ¹ÙÀÌ¿À º¸¾È °èȹ¿¡¼­ ¿ì¼±¼øÀ§°¡ µÇ°í ÀÖ½À´Ï´Ù.

¸» Áø´Ü ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

¸» Áø´Ü ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀº ¼öÀÇÇÐ Çõ½Å, ¼º´É ¸ð´ÏÅ͸µ, µ¿¹° °Ç°­ ¿ì¼±¼øÀ§ ÁöÁ¤°ú °ü·ÃµÈ ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Áúº´À» Á¶±â¿¡ Á¤È®ÇÏ°Ô °¨ÁöÇÏ´Â °Í¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÇÇè½Ç ¹× ¿µ»ó ±â¹Ý Áø´Ü¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼º´É È£½ºÀÇ ³ôÀº »ó¾÷Àû °¡Ä¡·Î ÀÎÇØ ºÎ»ó ¿¹¹æ, ¹ø½Ä ´É·Â Æò°¡, ü·Â ÃÖÀûÈ­¸¦ À§ÇÑ Á¤±âÀûÀÎ °Ë»ç°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.

¸ð¹ÙÀÏ Áø´Ü, µðÁöÅÐ ¿µ»ó Áø´Ü, À¯ÀüÀÚ °Ë»ç µîÀÇ ±â¼ú ¹ßÀüÀ¸·Î ´Ù¾çÇÑ ¸» Áý´Ü¿¡¼­ °í±Þ ¼­ºñ½º¸¦ º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¸ð¹ÙÀÏ ·¦°ú ¿Â¶óÀÎ ¼­ºñ½º Ç÷§ÆûÀÇ º¸±ÞÀÌ È®´ëµÊ¿¡ µû¶ó ¿ø°ÝÁö³ª ¼­ºñ½º ¼Ò¿Ü Áö¿ª¿¡¼­µµ Áø´ÜÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ½ºÆ÷Ã÷ÀÇ ±ÔÁ¦ °¨µ¶°ú ¸»ÀÇ °Ç°­ º¸Çè¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ü°èÈ­µÈ Áø´Ü ·çƾÀÌ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿òÁ÷ÀÓÀº ¸»ÀÇ °ü¸® ¹× ¼º´É °ü¸®¿¡ ÀÖ¾î Àü¹®ÀûÀÎ Áø´Ü ¼­ºñ½ºÀÇ Áö¼ÓÀûÀÎ µµÀÔ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¼­ºñ½º(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ, X¼±, ÃÊÀ½ÆÄ, ³»½Ã°æ, ÀÚ±â°ø¸í¿µ»ó, ±âŸ ¼­ºñ½º), ¿ëµµ(Á¤Çü¿Ü°ú ¹× ¿Ü»óÇÐ, Á¾¾çÇÐ, ½ÉÀåÇÐ, ½Å°æÇÐ, È£Èí±â, Ä¡°ú, ±âŸ ¿ëµµ), ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ(µ¿¹° º´¿ø ¹× Ŭ¸®´Ð, Çмú ¹× ¿¬±¸±â°ü, ±âŸ ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Equine Diagnostic Services Market to Reach US$1.2 Billion by 2030

The global market for Equine Diagnostic Services estimated at US$800.4 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Computed Tomography Service, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$324.9 Million by the end of the analysis period. Growth in the X-ray Service segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$218.1 Million While China is Forecast to Grow at 10.5% CAGR

The Equine Diagnostic Services market in the U.S. is estimated at US$218.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$244.5 Million by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Equine Diagnostic Services Market - Key Trends & Drivers Summarized

How Are Diagnostic Services Enhancing Equine Healthcare and Performance Monitoring?

Equine diagnostic services support the detection, evaluation, and management of diseases, injuries, and performance issues in horses. These services include laboratory tests, imaging techniques, and physiological assessments that help veterinarians and equine caretakers maintain the health, productivity, and athletic readiness of horses. Diagnostic tools play a critical role in early intervention, especially for conditions that may not present visible symptoms until advanced stages.

Commonly offered diagnostics include blood profiles, fecal tests, joint fluid analysis, reproductive evaluations, and advanced imaging such as ultrasound, radiography, and endoscopy. These services are vital in detecting lameness, respiratory conditions, gastrointestinal issues, and infectious diseases. For competitive and breeding horses, diagnostics help assess fertility, monitor training impact, and prevent performance-related injuries. The increasing value placed on equine welfare and sports integrity is pushing demand for regular and accurate diagnostic testing.

What Innovations Are Advancing the Accuracy and Scope of Equine Diagnostics?

The field of equine diagnostics is benefitting from advances in imaging, molecular biology, and point-of-care testing. Digital radiography and portable ultrasound systems are allowing for faster, more detailed imaging at stables and race venues. Endoscopy is being used more frequently for respiratory and gastrointestinal tract assessment, particularly in performance horses. Wearable health monitors and gait analysis tools are emerging to support real-time movement tracking and biomechanical evaluation.

Laboratories are offering more refined blood and genetic testing, including hormonal assays, disease-specific markers, and hereditary condition screening. PCR-based assays are improving early detection of infectious diseases, while real-time biochemical analyzers are supporting faster turnaround in emergency settings. Mobile diagnostic units and digital platforms are expanding access to remote or rural locations, making it easier for veterinarians to offer advanced diagnostics at the point of care.

Which Segments and Stakeholders Are Fueling Diagnostic Service Adoption?

Racehorses, show jumpers, and breeding stock represent the highest demand segments for diagnostic services due to the high economic and reputational value of these animals. Owners, trainers, breeders, and equine veterinarians are primary stakeholders seeking data-driven tools to optimize health management and prevent losses. Large equine clinics, veterinary universities, and specialized labs form the core service providers, with many offering subscription-based or routine diagnostic packages.

In addition to elite horses, there is growing interest in diagnostics for recreational and therapy horses, driven by greater attention to animal welfare and preventive care. Insurance companies and regulatory bodies are also playing a role by mandating diagnostic tests for coverage eligibility and competition clearance. As awareness of zoonotic disease risks increases, early detection of equine pathogens is being prioritized in herd management and biosecurity planning.

What Is Driving Growth in the Equine Diagnostic Services Market?

Growth in the equine diagnostic services market is driven by several factors related to veterinary innovation, performance monitoring, and animal health prioritization. Rising demand for early and accurate disease detection is leading to greater reliance on laboratory and imaging-based diagnostics. The high commercial value of performance horses is prompting regular testing for injury prevention, fertility assessment, and fitness optimization.

Technological advances in portable diagnostics, digital imaging, and genetic screening are making sophisticated services more accessible across diverse equine populations. Broader availability of mobile labs and online service platforms is enabling diagnostics in remote or underserved areas. Regulatory oversight in sports and rising interest in equine health insurance are further supporting structured diagnostic routines. These dynamics are contributing to sustained adoption of professional diagnostic services in equine care and performance management.

SCOPE OF STUDY:

The report analyzes the Equine Diagnostic Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Computed Tomography Service, X-ray Service, Ultrasound Service, Endoscopy Service, Magnetic Resonance Imaging Service, Other Services); Application (Orthopedics & Traumatology Application, Oncology Application, Cardiology Application, Neurology Application, Respiratory Application, Dental Application, Other Applications); Service Provider (Veterinary Clinics & Hospitals Service Provider, Academics & Research Institutes Service Provider, Other Service Providers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â